In latest article with @Forbespolska we’ve been discussing about our startup, investors, development plans and breakthrough MTC-Y technology.

To read more —> https://www.forbes.pl/biznes/biotts-i-nosnik-transdermalny-leki-przyjmowane-przez-skore/rg6h2n4